Effects of black seed (Nigella sativa) on metabolic parameters in diabetes mellitus: A systematic review

Complementary Therapies in Medicine

Volumn 23, Issue 2, 2015, Pages 275-282

  Heshmati, Javad ^a   Namazi, Nazli ^b  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus; Glucose status; Lipid profile; Nigella sativa

Indexed keywords

GLUCOSE; INSULIN; LIPID; NIGELLA SATIVA EXTRACT; VEGETABLE OIL; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; PLANT EXTRACT;

ANTIOXIDANT ACTIVITY; BLACK CUMIN; DIABETES MELLITUS; DRUG EFFICACY; DRUG MECHANISM; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE ABSORPTION; HUMAN; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; METABOLIC PARAMETERS; NONHUMAN; PLANT SEED; REVIEW; SYSTEMATIC REVIEW; ANIMAL; BLOOD; CHEMISTRY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; METABOLISM;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; HYPOGLYCEMIC AGENTS; LIPIDS; NIGELLA SATIVA; PLANT EXTRACTS;

EID: 84926415940     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2015.01.013     Document Type: Review

References (37)

1. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5):1047-1053.
2. Zoungas S., Chalmers J., Ninomiya T., Li Q., Cooper M.E., Colagiuri S., et al. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia 2012, 55(3):636-643.
3. Nathan D.M. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care 2014, 37(1):9-16.
4. Bharti S.K., Srivastava A., Singh R. Review on effect of combination drug therapy on diabetes mellitus and its management. Population 2014, 5(10):90.
5. Mumu S.J., Saleh F., Are F., Afnan F., Ali L. Non-adherence to life-style modification and its factors among type 2 diabetic patients. Indian J Public Health 2014, 58(1):40.
6. Mirhoseini M., Baradaran A., Rafieian-Kopaei M. Medicinal plants, diabetes mellitus and urgent needs. J HerbMed Pharmacol 2014, 2(2):1-10.
7. World Health Organization. WHO traditional medicine strategy 2002-2005. Available at: http://apps.who.int/medicinedocs/en/d/Js2297e/.
8. Grover J.K., Yadav S., Vats V. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol 2002, 81(1):81-100.
9. Maobe M., Gatebe E., Gitu L., Rotich H. Preliminary phytochemical screening of eight selected medicinal herbs used for the treatment of diabetes, malaria and pneumonia in Kisii region, Southwest Kenya. Eur J Appl Sci 2013, 5(10):1-6.
10. Patel D.K., Prasad S.K., Kumar R., Hemalatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed 2012, 2(4):320-330.
11. Mathur M.L., Gaur J., Sharma R., Haldiya K.R. Antidiabetic properties of a spice plant Nigella sativa. J Endocrinol Metab 2011, 1(1):1-8.
12. Shrivastava R.M., Agrawal R.C., Parveen Z. A review on therapeutic applications of Nigella sativa. J Chem Chem Sci 2011, 4:241-248.
13. Abdelmeguid N.E., Fakhoury R., Kamal S.M., Al Wafai R.J. Effects of Nigella sativa and thymoquinone on biochemical and subcellular changes in pancreatic β-cells of streptozotocin-induced diabetic rats. J Diabetes 2010, 2(4):256-266.
14. Kanter M., Akpolat M., Aktas C. Protective effects of the volatile oil of Nigella sativa seeds on β-cell damage in streptozotocin-induced diabetic rats: a light and electron microscopic study. J Mol Histol 2009, 40(5-6):379-385.
15. Mansi K.M.S. Effects of oral administration of water extract of Nigella sativa on serum concentrations of insulin and testosterone in alloxan-induced diabetic rats. Pak J Biol Sci 2005, 8(8):1152-1156.
16. Kaatabi H., Bamosa A.O., Lebda F.M., Al Elq A.H., Al-Sultan A.I. Favorable impact of Nigella sativa seeds on lipid profile in type 2 diabetic patients. J Fam Community Med 2012, 19(3):155.
17. Bamosa A.O., Kaatabi H., Lebdaa F.M., Elq A.M., Al-Sultanb A. Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus. Indian J Physiol Pharmacol 2010, 54(4):344-354.
18. Sultan M.T., Butt M.S., Karim R., Zia-Ul-Haq M., Batool R., Ahmad S., et al. Nigella sativa fixed and essential oil supplementation modulates hyperglycemia and allied complications in streptozotocin-induced diabetes mellitus. Evid Based Complement Altern Med 2014, 2:1-10.
19. Meral I., Yener Z., Kahraman T., Mert N. Effect of Nigella sativa on glucose concentration, lipid peroxidation, anti-oxidant defence system and liver damage in experimentally-induced diabetic rabbits. J Vet Med Series 2001, 48(10):593-599.
20. Kaleem M., Kirmani D., Asif M., Ahmed Q., Bano B. Biochemical effects of Nigella sativa L. seeds in diabetic rats. Indian J Exp Biol 2006, 44(9):745.
21. Houcher Z., Boudiaf K., Benboubetra M., Houche B. Effects of methanolic extract and commercial oil of Nigella sativa L. on blood glucose and antioxidant capacity in alloxan-induced diabetic rats. Pteridines 2007, 18:8-18.
22. Kanter M. Effects of Nigella sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy. Neurochem Res 2008, 33(January (1)):87-96.
23. Kanter M., Coskun O., Korkmaz A., Oter S. Effects of Nigella sativa on oxidative stress and beta-cell damage in streptozotocin-induced diabetic rats. Anat Rec A Discov Mol Cell Evol Biol 2004, 279(1):685-691.
24. Kanter M., Meral I., Yener Z., Ozbek H., Demir H. Partial regeneration/proliferation of the beta-cells in the islets of Langerhans by Nigella sativa L. in streptozotocin-induced diabetic rats. Tohoku J Exp Med 2003, 201(4):213-219.
25. Salama R.H.M. Hypoglycemic effect of lipoic acid, carnitine and Nigella sativa in diabetic rat model. Int J Health Sci 2011, 5(2):126.
26. Alimohammadi S., Tavakoli M., Hobbenaghi R., Khadivar F., Javanbakht J., Akbari H. Protective and antidiabetic effects of extract from Nigella sativa on blood glucose concentrations against streptozotocin (STZ)-induced diabetic in rats: an experimental study with histopathological evaluation. Diagn Pathol 2013, 8:137-144.
27. Rchid H., Chevassus H., Nmila R., Guiral C., Petit P., Chokai{dotless}rid M., et al. Nigella sativa seed extracts enhance glucose-induced insulin release from rat-isolated Langerhans islets. Fundam Clin Pharmacol 2004, 18:525-529.
28. Meddah B., Ducroc R., El Abbes Faouzi M., Eto B., Mahraoui L., Benhaddou-Andaloussi A., et al. Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats. J Ethnopharmacol 2009, 121(3):419-424.
29. Benhaddou-Andaloussi A., Martineau L., Vallerand D., Haddad Y., Afshar A., Settaf A., et al. Multiple molecular targets underlie the antidiabetic effect of Nigella sativa seed extract in skeletal muscle, adipocyte and liver cells. Diabetes Obes Metab 2010, 12(2):148-157.
30. Fararh K.M., Ibrahim A.K., Elsonosy Y.A. Thymoquinone enhances the activities of enzymes related to energy metabolism in peripheral leukocytes of diabetic rats. Res Vet Sci 2010, 88(3):400-404.
31. Losso J.N., Bawadi H.A., Chintalapati M. Inhibition of the formation of advanced glycation end products by thymoquinone. Food Chem 2011, 128:55-61.
32. Yin H., Xu L., Porter N.A. Free radical lipid peroxidation: mechanisms and analysis. Chem Rev 2011, 111(10):5944-5972.
33. Kendall D.M., Rubin C.J., Mohideen P., Ledeine J.-M., Belder R., Gross J., et al. Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a double-blind, randomized, pioglitazone-comparative study. Diabetes Care 2006, 29(5):1016-1023.
34. Le P.M., Benhaddou-Andaloussi A., Elimadi A., Settaf A., Cherrah Y., Haddad P.S. The petroleum ether extracts of Nigella sativa seeds exert insulin sensitizing and lipid lowering action in rats. J Ethnopharmacol 2004, 94(2-3):251-259.
35. Haque S.F., Najmi M.N.A. Indigenous herbal product Nigella sativa proved effective as an anti-obesity therapy in metabolic syndrome. Int J Med Res 2011, 1(3):173-176.
36. Najmi A., Haque S.F., Naseeruddin M., Khan R.A. Effect of Nigella sativa oil on various clinical and biochemical parameters of metabolic syndrome. Int J Diabetes Dev Ctries 2008, 16:85-87.
37. Akova A., Ustun G. Activity and adsorption of lipase from Nigella sativa seeds. Biotechnol Lett 2000, 22(5):355-359.